Health News Roundup: Denmark reports bird flu outbreak on turkey farm, WOAH says; Uganda confirms Ebola case in country's east as outbreak expands and more
20. South Africa reports bird flu outbreak on small farm - WOAH South Africa reported an outbreak of highly pathogenic H5N2 bird flu on a farm in the eastern part of the country, the Paris-based World Organisation for Animal Health (WOAH) said on Monday, citing a report from local authorities.
Following is a summary of current health news briefs.
Denmark reports bird flu outbreak on turkey farm, WOAH says
Denmark has reported an outbreak of highly pathogenic H5N1 avian influenza, or bird flu, on a turkey farm, the Paris-based World Organisation for Animal Health (WOAH) said on Monday. The outbreak in the small town of Lundby killed 204 birds, with the rest of the 33,600-strong flock slaughtered, WOAH said in a report, citing information from the Danish authorities.
Uganda confirms Ebola case in country's east as outbreak expands
An Ebola case has been confirmed in Jinja in eastern Uganda, the country's health minister said on Sunday, the first time the outbreak has spread to a new region of the country from central Uganda where cases have been confined so far. Authorities have been struggling to contain the highly infectious and deadly hemorrhagic fever since the epidemic was declared on Sept. 20.
New China COVID rules spur concern as some cities halt routine tests
Several Chinese cities began cutting routine community COVID-19 testing on Monday, days after China announced an easing of some of its heavy-handed coronavirus measures, sparking worry in some communities as nationwide cases continued to rise. In the northern city of Shijiazhuang, some families expressed concern about exposing their children to the virus at school, giving excuses such as toothaches or earaches for their children's absence, according to social media posts following a state media report that testing in the city would end.
Less and late: UK gives $1 billion to global disease fight
The British government said on Monday it would contribute 1 billion pounds ($1.18 billion) to the Global Fund to fight AIDS, tuberculosis and malaria, more than six weeks after other countries made their commitments. The total, which covers 2023-25, is 30% less than Britain pledged during the previous funding round in 2019, and below the 1.8 billion pounds requested this time.
Germany's BioNTech says to set up mRNA vaccine facility in Singapore
BioNTech SE, the German biotech that developed a widely used COVID-19 vaccine with Pfizer Inc, acquired a manufacturing facility in Singapore, its first in Asia, the company said on Monday. The facility, bought from a Novartis unit, will be its first messenger ribonucleic acid, or mRNA, facility in Singapore and support its vaccines production for the Asia Pacific region, BioNTech said in a statement, without disclosing financial details.
U.S. judge rejects Biden administration's LGBT health protections
A federal judge in Texas ruled on Friday that President Joe Biden's administration had wrongly interpreted an Obamacare provision as barring health care providers from discriminating against gay and transgender people. U.S. District Judge Matthew Kacsmaryk in Amarillo ruled that a landmark U.S. Supreme Court decision in 2020 holding that a law barring workplace discrimination protects gay and transgender employees did not apply to the healthcare law.
South Africa reports bird flu outbreak on small farm - WOAH
South Africa reported an outbreak of highly pathogenic H5N2 bird flu on a farm in the eastern part of the country, the Paris-based World Organisation for Animal Health (WOAH) said on Monday, citing a report from local authorities. Some 58 "domestic birds" of a total flock of 200 were found dead of the highly contagious virus, the report said, without giving additional details on the type of birds.
Moderna's Omicron shots shows better immune response than original COVID vaccine
Moderna Inc said on Monday its Omicron-tailored vaccines produced a better immune response against the BA.4/5 subvariants in a mid-to-late stage study, when given as a booster dose, compared with its original shot. Data shows that both of Moderna's Omicron-tailored shots, mRNA-1273.214 and mRNA-1273.222, produced a higher antibody response against BA.4/5 subvariants than its original shot in vaccinated and boosted adults, the company said.
Satsuma Pharma's migraine drug fails in late-stage study
Satsuma Pharmaceuticals Inc said on Monday its experimental migraine drug failed to meet the main goals of a late-stage trial. The drug, STS101, was not statistically significant in improving key measures such as freedom from pain and other bothersome symptoms, when compared to placebo at two hours post-administration, the company said.
Roche's Alzheimer's drug fails to meet goal in long-awaited trial
Roche's Alzheimer's drug candidate could not be shown to slow dementia progression in two drug trials, leaving rivals Biogen and Eisai as leaders in a high-stakes race to launch a treatment for the memory-robbing disease. Roche said in a statement on Monday that twin studies known as Graduate 1 and 2 had not reached their main goal of showing that the drug gantenerumab could preserve abilities such as remembering, solving problems, orientation and personal care in patients suffering from early stages of Alzheimer's disease.
(With inputs from agencies.)